BioSpace News Archive

Vault Product Surveillance will speed reporting to health authorities for improved product quality and patient safety

Brands will now have complete insight into field and marketing activity to better assess and optimize impact across channels

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIject™ as a highly promising treatment [29-April-2020] WAVRE, Belgium , April 29, 2020 /PRNewswire/ -- iSTAR Medical SA , a clinical-stage medical device company pioneering truly biocompatible solutions for glaucoma, today announced positive results from two clinical trials

Only AI solution in Korea to prove high effectiveness through clinical trials carried out by three major hospitals

Avantor, Inc., a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, reported financial results for the first quarter ended March 31, 2020.

Jazz Pharmaceuticals plc announced that enrollment in the Phase 3 clinical study of defibrotide for the prevention of hepatic veno-occlusive disease post-hematopoietic stem-cell transplantation in high-risk or very high-risk patients is being discontinued.

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the United States Food and Drug Administration (FDA) Office of Orphan Products

Innoviva, Inc. (NASDAQ:INVA) (“Innoviva,” or “the Company”) today reported financial results for the first quarter ended March 31, 2020.

Hologic, Inc. (Nasdaq: HOLX) announced today that it plans to launch a new Aptima® molecular assay to detect the SARS-CoV-2 virus that will run on its market-leading Panther® system.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced its first quarter 2020 financial results and business highlights.